US FDA approves Amgen's Uplizna as first treatment for rare immune disorder - Reuters

Reuters | April 3, 2025, 4:29 p.m. | Original
US FDA approves Amgen's Uplizna as first treatment for rare immune disorder Reuters
TSX posts biggest decline in five years on US tariff shock - Reuters AbbVie cuts 2025 profit forecast on acquisition expenses - Reuters